Zydus Lifesciences Ltd
Ticker: ZYDUSLIFE
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
977.30
Market Cap
98339.25
Debt/Equity
0.1219
ROE %
18.677
PB
3.7309
Promoter %
74.995
Pledge %
0.000
1Y Rev Growth %
18.396
5Y Rev Growth %
10.352
NP Margin %
19.248
NP Margin 5Y Avg %
18.013
Trading Reference
1M Return %
-5.981
6M Return %
10.661
1Y Return %
-7.641
% Away 52W High
9.664
% Away 52W Low
22.931
Daily Volume
563166
Investment Verdict
Hold
Score 72/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 42/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Zydus Lifesciences Ltd is likely to experience moderate upside potential in the medium-term, with key resistance levels around ₹500. If it breaks above this level, it could see further gains. However, there is a risk of downside if it falls below the support level of ₹450, which could lead to a decline.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
W
Waaree Energies Ltd
Waaree Energies Ltd shows potential in the renewable energy sector, but faces challenges in profitability and execution risks.
View details
U
Union Bank of India Ltd
Union Bank of India shows moderate potential with some growth prospects, but faces challenges in profitability and execution risks.
View details
C
Canara Bank Ltd
Canara Bank shows potential for moderate growth but faces challenges in profitability and execution risks.
View details
I
IDBI Bank Ltd
IDBI Bank Ltd presents a risky investment opportunity with moderate growth and profitability concerns.
View details
A
Adani Energy Solutions Ltd
Adani Energy Solutions Ltd shows potential in a growing sector, but faces significant challenges that could impact its performance.
View details
H
Havells India Ltd
Havells India Ltd shows a decent investment opportunity with strong growth potential, but investors should be cautious of valuation and execution risks.
View details
R
REC Limited
REC Limited shows potential for growth in a vital sector, but investors should be cautious of execution risks and governance issues.
View details
S
Swiggy Ltd
Swiggy Ltd shows potential for growth but faces significant challenges in profitability and competition. Caution is advised.
View details
D
Dabur India Ltd
Dabur India Ltd shows decent fundamentals with consistent growth and a strong balance sheet, but valuation concerns and execution risks need to be monitored.
View details
I
Indus Towers Ltd
Indus Towers Ltd shows potential in a growing sector but faces challenges in execution and market competition.
View details
M
Marico Ltd
Marico Ltd shows a decent investment opportunity with stable growth and profitability metrics, though some risks remain.
View details
U
United Spirits Ltd
United Spirits Ltd shows potential for growth, but faces challenges in profitability and valuation metrics.
View details
I
ICICI Lombard General Insurance Company Ltd
ICICI Lombard shows potential but faces challenges in profitability and competitive pressures.
View details
I
Indian Bank
Indian Bank shows potential but faces challenges in growth consistency and market competition.
View details
L
Lupin Ltd
Lupin Ltd shows potential for growth but faces several challenges that could impact its performance.
View details
B
Bajaj Housing Finance Ltd
Bajaj Housing Finance Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics. Caution is advised due to execution risks.
View details
Business Overview
Zydus Lifesciences Ltd is a leading Indian pharmaceutical company dedicated to improving healthcare through innovative solutions. With a strong focus on research and development, Zydus caters to a diverse range of therapeutic areas, making it a trusted partner for healthcare professionals and patients alike. The company’s commitment to quality and affordability ensures that essential medicines are accessible to all, contributing to better health outcomes across India.
- Established leader in the Indian pharmaceutical sector
- Strong focus on research and innovation
- Wide range of therapeutic offerings
- Commitment to quality and affordability
- Trusted by healthcare professionals and patients
- Contributes to improved health outcomes in India
Investment Thesis
Zydus Lifesciences Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth and make it a compelling investment opportunity for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services, tapping into modern healthcare trends.
- Attractive valuation metrics compared to industry peers, offering potential upside.
- Diverse product portfolio strengthens market position and revenue streams.
- Commitment to R&D ensures innovation and long-term sustainability.
Opportunity vs Risk
Opportunities
- Strong pipeline of new drugs
- Growing demand for generics
- Expansion into international markets
- Strategic partnerships with global firms
Risks ⚠️
- Regulatory challenges in India
- Intense competition in generics
- Currency fluctuations affecting profits
- Dependence on a few key products
Peer Perspective
Zydus Lifesciences Ltd trades at a discount to peers like Sun Pharma and Dr. Reddy's, reflecting concerns over margin stability; a sustained improvement in operational efficiency could trigger a rerating.
Future Outlook
Zydus Lifesciences Ltd is well-positioned for growth with its robust pipeline and expanding global footprint; however, successful execution and cost control will be critical to maximize shareholder value in the coming years.
AI FAQs for Retail Users
- Q: What does Zydus Lifesciences Ltd do?A: Zydus Lifesciences Ltd is a pharmaceutical company focused on developing and manufacturing generic and innovative medicines.
- Q: Is Zydus Lifesciences Ltd a good investment?A: Investment decisions should consider personal financial goals and market conditions; consult a financial advisor for tailored advice.
- Q: What are the key products of Zydus Lifesciences Ltd?A: The company offers a range of products including pharmaceuticals, vaccines, and consumer healthcare items.
- Q: How has Zydus Lifesciences Ltd performed recently?A: Recent performance can be checked through financial news and stock market updates for the latest insights.
- Q: What are the risks associated with investing in Zydus Lifesciences Ltd?A: Like all stocks, risks include market volatility, regulatory changes, and company-specific challenges.
📊 Stock Investment Checklist (100 Points)
Zydus Lifesciences Ltd • Updated: 2025-09-18 08:52:27
-
10BusinessHighPharmaceutical sector is essential and growing, but competition is intense.
-
10GrowthHighConsistent revenue growth observed, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow has been inconsistent.
-
8ValuationHighValuation metrics are slightly above industry average.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
6GovernanceGoodPromoter holding is stable, but some concerns over pledging.
-
5DriversGoodGrowth drivers exist, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is mixed, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Zydus Lifesciences Ltd shows potential for growth, but faces challenges in profitability and market competition.